Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial
2020 · Circulation · 211 citations
https://doi.org/10.1161/circulationaha.120.048728
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
2.9K
Citations
15
h-index
18
i10-index
Nathan M. Segerson is an academic researcher from Boston Scientific (United States). The author has contributed to research in topics: Cardiac Arrhythmias and Treatments & Atrial Fibrillation Management and Outcomes & Cardiac electrophysiology and arrhythmias. The author has an h-index of 15, co-authored 34 publications.
https://doi.org/10.1161/circulationaha.120.048728
https://doi.org/10.1111/j.1540-8167.2007.00879.x
Click to start Chat